The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $602,494 in first-year total cost, median $301,247.
Most frequent study sections
- Special Emphasis Panel[ZAI1 BJM-A (M1)]1
- Special Emphasis Panel[ZAI1 VS-A (S1)]1
Most frequent institutions
- HBVTECH1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Hematopoietic Stem/Progenitor Cell-Based Chimeric Antigen Receptor Gene Therapy for HIV Infection1R34AI188541-01 | KITCHEN, SCOTT G | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $343,744 | ZAI1 |
| 2025 | A development strategy to obtain IND approval of HBVZ10, a new HBV cure therapy candidate1R34AI194337-01 | ZHANG, YONG-YUAN | HBVTECH, MD | $258,750 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.